IRF8 mutant CMS4.K79E cells exhibited decreased sensitivity to 2/20 CTL-induced cell killing as compared to the vector control cells (Figure 4D), indicating that IRF8 regulates 2/20 CTL-induced tumor cell death. The gene discussed is IRF8; the disease is neoplasm.